Dissolution stability and IVIVC investigation of a buccal tablet

European Pharmacopoeia, 3rd Edition, 1997–2001. USP XXIV, NF 19, 2000. FDA Guidance for Industry: Immediate Release Solid Dosage Forms, Scale-up and Post-approval Changes (SUPAC-IR), Chemistry, Manufacturing and Controls, In-vitro Dissolution Testing and In-vivo Bioequivalence Documentation, November 1995. FDA Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, August 1997. FDA Guidance for Industry: Extended Release Oral Dosage Forms, Development, Evaluation and Application of In-vivoIn-vitro Correlations, September, 1997. FDA Guidance for Industry: Modified Release Oral Dosage Forms, Scale-up and Post-approval Changes (SUPAC-MR), Chemistry, Manufacturing and Controls, In-vitro Dissolution Testing and In-vivo Bioequivalence Documentation, September 1997. Sathe, 1996, In-vitro dissolution profile comparison: statistics and analysis, model-dependent approach, Pharm. Res., 13, 1799, 10.1023/A:1016020822093 Lee, 1999, Analysis of drug dissolution data, Stat. Med., 18, 799, 10.1002/(SICI)1097-0258(19990415)18:7<799::AID-SIM81>3.0.CO;2-Y Polli, 1997, Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets, J. Pharm. Sci., 86, 690, 10.1021/js960473x R. De Maesschalck, Chemometric characterisation of pharmaceutical substances and products, Ph.D. thesis, Free University of Brussels, 2000. L. Van Vooren, G. Krikilion, J. Rosier, B. De Spiegeleer, A novel bending point criterion for dissolution profile interpretation, Drug Development and Industrial Pharmacy, 2001, in press. Committee for Proprietary Medicinal Products (CPMP): Note for Guidance on Stability Testing of Existing Active Substances and Related Finished Products, October 1998. J.K. Lindsey, Parametric Statistical Inference, Clarendon Press, Oxford, 1996.